Oct 2024 - Pro Medicus Limited (ASX:PME), a leading player in healthcare informatics, has announced a significant five-year contract extension valued at a minimum of $32 million with a prominent ...
Nyrada (ASX:NYR), a drug discovery company focused on small molecule therapies, has announced the successful completion of critical safety studies for its lead candidate NYR-BI03. The drug, designed ...
Clarity Pharmaceuticals has reported significant developments in its SECuRE trial, which is evaluating the efficacy of 67Cu-SAR-bisPSMA for the treatment of prostate cancer. The t ...
Oct 2024 - Imricor Medical Systems (ASX:IMR) has reported significant progress in its latest quarterly update, including a milestone achievement with the first MRI-guided ablation on US soil at Johns ...
Oct 2024 - Bank of Queensland (ASX: BOQ) has announced its FY24 results, reporting a significant rise in statutory net profit after tax to $285 million, a 130% increase from FY23. However, cash ...